VIDEO: Adoptive T-cell therapy poised to become ‘mainstay’ in myeloma treatment paradigm
tvdwal2019-01-29T13:16:59+01:00BEKIJK DE VIDEO Ivan Borrello, MD, associate professor of oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, talks about the potential of adoptive T-cell therapies in the treatment of multiple myeloma. Offering an overview of how chimeric antigen receptor (CAR) T-cell therapy works — from gene modification to antibody expression to protein targets — Borrello discusses distinct approaches currently under investigation. “The rationale for targeting myeloma with a CD19 is … has significant biological appeal [...]